Biomarin Pharmaceutical (BMRN) Current Deferred Tax Assets (2010 - 2015)
Biomarin Pharmaceutical's (BMRN) quarterly Current Deferred Tax Assets came in at $30.9 million in Q3 2015, up 5.94% YoY from $29.1 million in Q3 2014, and down 1.04% on a QoQ basis from $31.2 million in Q2 2015.
Biomarin Pharmaceutical (BMRN) Current Deferred Tax Assets (2010 - 2015) Analysis & Trends
Biomarin Pharmaceutical (BMRN) has 6 years of Current Deferred Tax Assets data on file, last reported at $30.9 million in Q3 2015.
- Quarterly Current Deferred Tax Assets rose 5.94% year-over-year to $30.9 million in Q3 2015, while the trailing twelve-month figure through Sep 2015 was $30.9 million (up 5.94% YoY) and the FY2014 annual result came in at $31.2 million, up 2.09% from the prior year.
- Current Deferred Tax Assets eased to $30.9 million in Q3 2015, from $31.2 million in the prior quarter.
- In the past five years, Current Deferred Tax Assets ranged from a high of $32.4 million in Q4 2012 to a low of $16.7 million in Q2 2011.
- A 5-year average of $27.2 million and a median of $30.0 million in 2013 frame the typical range for Current Deferred Tax Assets.
- Annual changes were most pronounced in 2012 — Current Deferred Tax Assets soared 53.24% — and 2014, when it fell 9.58%.
- Tracing BMRN's Current Deferred Tax Assets over 5 years: stood at $21.1 million in 2011, then soared by 53.24% to $32.4 million in 2012, then declined by 5.55% to $30.6 million in 2013, then rose by 2.09% to $31.2 million in 2014, then dropped by 1.03% to $30.9 million in 2015.
- The last three Current Deferred Tax Assets figures came in at $30.9 million (Q3 2015), $31.2 million (Q2 2015), and $31.2 million (Q1 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Biomarin Pharmaceutical | 13.04 Bn | 12.16 Bn | 786.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | 30.88 Mn |
| Sep 30, 2015 | 30.88 Mn |
| Jun 30, 2015 | 31.20 Mn |
| Jun 30, 2015 | 31.20 Mn |
| Mar 31, 2015 | 31.20 Mn |
| Mar 31, 2015 | 31.20 Mn |
| Dec 31, 2014 | 31.20 Mn |
| Dec 31, 2014 | 31.20 Mn |
| Sep 30, 2014 | 29.15 Mn |
| Sep 30, 2014 | 29.15 Mn |
| Jun 30, 2014 | 30.56 Mn |
| Jun 30, 2014 | 30.56 Mn |
| Mar 31, 2014 | 30.56 Mn |
| Mar 31, 2014 | 30.56 Mn |
| Dec 31, 2013 | 30.56 Mn |
| Dec 31, 2013 | 30.56 Mn |
| Sep 30, 2013 | 32.24 Mn |
| Sep 30, 2013 | 32.24 Mn |
| Jun 30, 2013 | 29.47 Mn |
| Jun 30, 2013 | 29.47 Mn |